Apogee Therapeutics, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
APGE on Nasdaq
Location
221 Crescent St., Building 17, Suite 102 B, Waltham, MA

Insiders trading volume in the past year

Apogee Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director $80.1M Jun 5, 2024
Nimish Shah Director $65.2M Jun 5, 2024
Michael Henderson Chief Executive Officer, Director $62.5M -$7.92M -11.3% Dec 9, 2024
Carl Dambkowski Chief Medical Officer $12.9M -$2.14M -14.2% Dec 11, 2024
Jane Henderson Chief Financial Officer $9.69M -$290K -2.9% Dec 9, 2024
William Jones Director $1.3M Jun 5, 2024
Jennifer A. Fox Director $1.3M Jun 5, 2024
Mark McKenna Director $997K +$991K +15916% Dec 12, 2024
Andrew Gottesdiener Director Jun 5, 2024
Lisa Bollinger Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Apogee Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.